LEWIS JOSEPH 4
Accession 0000899243-21-010812
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 9:48 PM ET
Size
31.4 KB
Accession
0000899243-21-010812
Insider Transaction Report
- Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying) - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying)
- Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying)
- Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying)
- Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total
- Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying)
- Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying)
- Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying)
- Sale
Common Stock
2021-03-05$181.15/sh−37,000$6,702,550→ 230,333 total - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+13,996$14→ 267,334 total - Sale
Common Stock
2021-03-05$181.15/sh−363,000$65,757,450→ 2,000,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996$78,364→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (13,996 underlying) - Exercise/Conversion
Common Stock
2021-03-05$0.00/sh+597,444$597→ 2,363,004 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805$721,179→ 0 totalExercise: $0.00From: 2017-01-06→ Common Stock (128,805 underlying) - Sale
Common Stock
2021-03-05$181.00/sh−1$181→ 267,333 total - Sale
Common Stock
2021-03-05$181.00/sh−4$724→ 2,363,000 total - Exercise/Conversion
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639$6,091,838→ 332,809 totalExercise: $0.00From: 2017-11-20→ Common Stock (468,639 underlying)
Footnotes (4)
- [F1]These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
- [F2]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, LLC ("Boxer Capital") (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) MVA Investors, LLC ("MVA Investors"), (v) Lockend Five, LLC ("Lockend Five"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the "Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital.
- [F3](Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
- [F4]The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Related Parties
1- filerCIK 0001015747
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 9:48 PM ET
- Size
- 31.4 KB